| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1043975731 |
| P356 | DOI | 10.1007/S11886-016-0732-Y |
| P698 | PubMed publication ID | 27108363 |
| P50 | author | Hugh Calkins | Q67190496 |
| P2093 | author name string | Gabriela M Orgeron | |
| P2860 | cites work | Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement | Q26799094 |
| Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q28268639 | ||
| Arrhythmogenic right ventricular dysplasia: a United States experience | Q33153393 | ||
| Right ventricular dysplasia: a report of 24 adult cases | Q34714742 | ||
| Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. | Q34782131 | ||
| Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations. | Q35115127 | ||
| Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. | Q35673091 | ||
| Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy | Q35813210 | ||
| Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiom | Q35847506 | ||
| Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia | Q36791125 | ||
| Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. | Q37259910 | ||
| Cardiac MR findings and potential diagnostic pitfalls in patients evaluated for arrhythmogenic right ventricular cardiomyopathy | Q38259638 | ||
| Arrhythmogenic right ventricular dysplasia/cardiomyopathy-three decades of progress | Q38422786 | ||
| Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Sc | Q38654218 | ||
| Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members | Q41144205 | ||
| Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital. | Q50752338 | ||
| Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. | Q51023298 | ||
| Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. | Q51329457 | ||
| Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers. | Q52920761 | ||
| Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. | Q53291585 | ||
| Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. | Q54283083 | ||
| Does sports activity enhance the risk of sudden death in adolescents and young adults? | Q55037940 | ||
| Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. | Q55638651 | ||
| Spectrum of Biventricular Involvement on CMR Among Carriers of ARVD/C-Associated Mutations | Q57735979 | ||
| Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy | Q57736293 | ||
| Diagnostic Value of Isoproterenol Testing in Arrhythmogenic Right Ventricular Cardiomyopathy | Q62814145 | ||
| Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes | Q82907387 | ||
| Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention | Q84974205 | ||
| High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q85812758 | ||
| Arrhythmogenic right ventricular dysplasia | Q86245500 | ||
| Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers | Q86589091 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 53 | |
| P577 | publication date | 2016-06-01 | |
| P1433 | published in | Current cardiology reports | Q26842345 |
| P1476 | title | Advances in the Diagnosis and Management of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy | |
| P478 | volume | 18 |
Search more.